Debuigne, A., Piel, G., Mottet, D., Toussaint, F., Berger, M., Ben Djemaa, S., & Lechanteur, A. (07 November 2024). Polymer derivatives and their use as lipid nanoparticle modifiers. |
Debuigne, A., Piel, G., Mottet, D., Toussaint, F., Berger, M., Ben Djemaa, S., & Lechanteur, A. (06 November 2024). Polymer derivatives and their use as lipid nanoparticle modifiers. |
  | Nyamba, I., Sombie, C. B., Yabre, M., Zime-Diawara, H., Yameogo, J., Ouedraogo, S., Lechanteur, A., Semde, R., & Evrard, B. (21 September 2024). Pharmaceutical approaches for enhancing solubility and oral bioavailability of poorly soluble drugs. European Journal of Pharmaceutics and Biopharmaceutics, 204, 114513. doi:10.1016/j.ejpb.2024.114513  Peer Reviewed verified by ORBi |
Bya, L.-A., Coeurderoi, A., Dinh, T. N., Bottero, B., Sacre, P.-Y., Ziemons, E., Cataldo, D., Piel, G., Lechanteur, A., & Evrard, B. (12 September 2024). Formulation of a Dry Powder for Inhalation Combining Ciclesonide and Indacaterol [Paper presentation]. Exploring the Future of Inhalation Drug Delivery, Parme, Italy. |
  | Nyamba, I., Wanko Nembot, A. M., Sombié B Charles, Zimé - Diawara Hermine, Yaméogo B.G Josias, Lechanteur, A., Damblon, C., Semdé Rasmané, & Evrard, B. (20 July 2024). Evaluation of the application of polyethylene glycol 8000 as a plasticizer for the development of solid dispersions based on ellagic acid and Eudragit® EPO using hot melt extrusion. Journal Africain de Technologie Pharmaceutique et Biopharmacie, Vol.3 Nº1 2024. doi:10.57220/jatpb.v3i1.179 Editorial Reviewed verified by ORBi |
 | Nyamba, I., Charles B. SOMBIE, Lechanteur, A., Rasmané SEMDE, & Evrard, B. (2024). Potential of Native Cyclodextrins and L-Lysine for Enhancing Ellagic Acid Aqueous Solubility. International Journal of Drug Delivery Technology. doi:10.25258/ijddt.14.2.48 Peer reviewed |
Lechanteur, A. (18 June 2024). Production of drug-loaded filaments by hot melt extrusion for 3D printing [Paper presentation]. APV - Worshop on HME, Karlsruhe, Germany. |
Lechanteur, A. (June 2024). What is the future of 3D printing technique (FDM) in community or hospital pharmacies for the production of oral solid dosage forms ? [Paper presentation]. 13ième JSM Journée Scientifique du Médicament. |
 | Koch, N., Jennotte, O., Bourcy, Q., Lechanteur, A., DEVILLE, M., Charlier, C., CHIAP, P., Cardot, J. M., & Evrard, B. (27 April 2024). Evaluation of amorphous and lipid-based formulation strategies to increase the in vivo cannabidiol bioavailability in piglets. International Journal of Pharmaceutics, 657, 124173. doi:10.1016/j.ijpharm.2024.124173 Peer Reviewed verified by ORBi |
Debuigne, A., Berger, M., Toussaint, F., Ben Djemaa, S., Jérôme, C., Lechanteur, A., Mottet, D., & Piel, G. (24 April 2024). Poly(N-vinyl amide)-lipid conjugates as poly(ethylene glycol) alternatives for the modification of lipid-based nanocarriers [Paper presentation]. Materials Research Society (MRS) Spring Meeting, Seattle, United States. |
Ayyoubi, S., Jennotte, O., Lechanteur, A., Evrard, B., & Ruigjrok, L. (21 April 2024). Will 3D printing replace manual compounding? [Poster presentation]. PBP World meeting, Vienne, Austria. |
 | Bya, L.-A., Coeurderoi, A., Dinh, T. N., Bottero, B., Sacre, P.-Y., Ziemons, E., Cataldo, D., Piel, G., Lechanteur, A., & Evrard, B. (17 April 2024). Assessment of the Effects of Drying Methods on Powder Properties: A Comparative Study of Spray Drying from Solution and Suspension [Poster presentation]. 9th Workshop on Pulmonary Drug Delivery, Dublin, Ireland. |
Berger, M., Toussaint, F., Ben Djemaa, S., Maquoi, E., Pendeville-Samain, H., Evrard, B., Jérôme, C., Leblond Chain, J., Lechanteur, A., Mottet, D., Debuigne, A., & Piel, G. (March 2024). Innovative siRNA-based lipid nanoparticles decorated with PEG alternatives (PNVP and PNMVA) to circumvent dilemma and immunogenicity [Paper presentation]. 14th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical (PBP) Technology, Vienne, Austria. Peer reviewed |
 | Gresse, E., Rousseau, J., Akdim, M., Du Bois, A., Lechanteur, A., & Evrard, B. (2024). Enhancement of inhaled micronized powder flow properties for accurate capsules filling. Powder Technology, (119576). doi:10.1016/j.powtec.2024.119576 Peer Reviewed verified by ORBi |
Bya, L.-A., Coeurderoi, A., Dinh, T. N., Piel, G., Lechanteur, A., & Evrard, B. (31 January 2024). STUDY OF THE IMPACT OF DRYING PROCESSES ON POWDER PROPERTIES: A COMPARATIVE ANALYSIS OF SPRAY-DRYING TECHNOLOGY FROM SOLUTION AND SUSPENSION [Paper presentation]. CIRM day 2024 - Scientific Day, Liège, Belgium. |
Koch, N., Jennotte, O., Lechanteur, A., Grignard, B., & Evrard, B. (17 January 2024). Improvement of aqueous solubility of active pharmaceutical ingredients by using mesoporous silica impregnation under pressurized carbon dioxide [Paper presentation]. 1st FRITCO2T Day. Peer reviewed |
 | Koch, N., Jennotte, O., Lechanteur, A., DEVILLE, M., Charlier, C., Cardot Jean-Michel, CHIAP, P., & Evrard, B. (2024). An Intravenous Pharmacokinetic Study of Cannabidiol Solutions in Piglets through the Application of a Validated Ultra-High-Pressure Liquid Chromatography Coupled to Tandem Mass Spectrometry Method for the Simultaneous Quantification of CBD and Its Carboxylated Metabolite in Plasma. Pharmaceutics. doi:10.3390/pharmaceutics16010140 Peer Reviewed verified by ORBi |
Lechanteur, A. (28 November 2023). What is the future of 3D printing technique (FDM) in community or hospital pharmacies for the production of oral solid dosage forms ? [Paper presentation]. 3DMedical Conference. Peer reviewed |
 | Berger, M.* , Toussaint, F.* , Djemaa, S. B.* , Maquoi, E., Pendeville-Samain, H., Evrard, B., Jérôme, C., Chain, J. L., Lechanteur, A., Mottet, D.* , Debuigne, A.* , & Piel, G.*. (2023). Poly(N-methyl‐N‐vinylacetamide): a strong alternative to PEG for lipid‐based nanocarriers delivering siRNA. Advanced Healthcare Materials, 2302712. doi:10.1002/adhm.202302712 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
 | Jennotte, O., Koch, N., Lechanteur, A., & Evrard, B. (September 2023). Formulation and quality consideration of cannabidiol printed forms produced by fused-deposition modeling. Journal of Drug Delivery Science and Technology, 87, 104837. doi:10.1016/j.jddst.2023.104837 Peer reviewed |
 | Lechanteur, A., Gresse, E., Orozco, L., Plougonven, E., Léonard, A., Vandewalle, N., Lumay, G., & Evrard, B. (16 August 2023). Inhalation powder development without carrier: how to engineer ultra-flying microparticles? European Journal of Pharmaceutics and Biopharmaceutics, 191, 26 - 35. doi:10.1016/j.ejpb.2023.08.010 Peer Reviewed verified by ORBi |
 | Berger, M.* , Toussaint, F.* , Djemaa, S. B.* , Laloy, J., Pendeville-Samain, H., Evrard, B., Jérôme, C., Lechanteur, A., Mottet, D.* , Debuigne, A.* , & Piel, G.*. (02 August 2023). Poly(vinyl pyrrolidone) derivatives as PEG alternatives for stealth, non-toxic and less immunogenic siRNA-containing lipoplex delivery. Journal of Controlled Release, 361, 87 - 101. doi:10.1016/j.jconrel.2023.07.031 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
 | Parulski, C., Bya, L.-A., Goebel, J., Servais, A.-C., Lechanteur, A., & Evrard, B. (13 June 2023). Development of 3D printed mini-waffle shapes containing hydrocortisone for children's personalized medicine. International Journal of Pharmaceutics, 642 (123131). doi:10.1016/j.ijpharm.2023.123131 Peer Reviewed verified by ORBi |
Dinh, T. N., Bya, L.-A., Lechanteur, A., Penoy, N., Evrard, B., & Piel, G. (28 April 2023). LIPOSOME FOR THE TREATMENT OF COPD PRODUCED BY SUPERCRITICAL CARBON DIOXIDE-BASED TECHNOLOGIES [Paper presentation]. 21st Forum of Pharmaceutical Sciences, Blankenberge, Belgium. |
Gresse, E., Rousseau, J., du Bois, A., Lechanteur, A., & Evrard, B. (27 April 2023). HOW TO IMPROVE ENGINEERED MICRONIZED POWDER FLOWABILITY? [Paper presentation]. 21st Forum of Pharmaceutical Sciences, Blankenberge, Belgium. |
Parulski, C., Bya, L.-A., Goebel, J., Servais, A.-C., Lechanteur, A., & Evrard, B. (27 April 2023). The future of 3D printing for personalized medicine: Could 3D printed waffle shapes replace the magistral preparation of hydrocortisone capsules? [Paper presentation]. 21st Forum of Pharmaceutical Sciences, Blankenberge, Belgium. |
Berger, M., Degey, M., Leblond Chain, J., Maquoi, E., Evrard, B., Lechanteur, A., & Piel, G. (27 April 2023). Effect of PEG anchor and serum on Lipid Nanoparticles: development of a nanoparticle tracking method [Paper presentation]. 21st Forum of Pharmaceutical Sciences, Blankenberge, Belgium. |
Berger, M., Degey, M., Leblond Chain, J., Maquoi, E., Evrard, B., Lechanteur, A., & Piel, G. (21 March 2023). Impact of the hydrophobic chain length of PEG derivatives on the behavior of LNPs in serum: Development of a Nanoparticle Tracking Analysis (NTA) Method [Poster presentation]. 4th European Conference on Pharmaceutics, Marseille, France. Peer reviewed |
Jennotte, O., Lechanteur, A., Koch, N., Evrard, B., Rosoux François, Emmerechts Carl, & Beeckman Eric. (20 March 2023). Formulation and Quality Consideration of Printed Tablets of Cannabidiol Produced by Direct Powder Extrusion [Poster presentation]. 4th European Conference on Pharmaceutics, Marseille, France. |
Parulski, C., Goebel, J., Bya, L.-A., Lechanteur, A., & Evrard, B. (20 March 2023). Could 3D printed waffle shapes replace the magistral preparation of hydrocortisone capsules for children’s personalized medicine? [Poster presentation]. 4th European Conference on Pharmaceutics, Marseille, France. |
Gresse, E., du Bois, A., Rousseau, J., Lechanteur, A., & Evrard, B. (20 March 2023). How to improve engineered micronized powder flowability? [Poster presentation]. 4th European Conference on Pharmaceutics, Marseille, France. |
 | Berger, M., Degey, M., Leblond Chain, J., Maquoi, E., Evrard, B., Lechanteur, A., & Piel, G. (10 February 2023). Effect of PEG Anchor and Serum on Lipid Nanoparticles: Development of a Nanoparticles Tracking Method. Pharmaceutics, 15 (2). doi:10.3390/pharmaceutics15020597 Peer Reviewed verified by ORBi |
Dinh, T. N., Bya, L.-A., Lechanteur, A., Penoy, N., Evrard, B., & Piel, G. (01 February 2023). Liposome containing ciclesonide with/without indacaterol produced by supercritical carbon dioxide-based technologies [Poster presentation]. CIRM Day, Liège, Belgium. |
Dinh, T. N., Bya, L.-A., Lechanteur, A., Penoy, N., Evrard, B., & Piel, G. (01 February 2023). Liposome containing ciclesonide with/without indacaterol produced by supercritical carbon dioxide-based technologies [Poster presentation]. CIRM Day, Liège, Belgium. |
Berger, M., Degey, M., Leblond Chain, J., Maquoi, E., Evrard, B., Lechanteur, A., & Piel, G. (01 February 2023). Effect of PEG anchor and serum on Lipid Nanoparticles: development of a nanoparticles tracking method [Paper presentation]. CIRM Day, Liege, Belgium. |
Koch, N., Jennotte, O., Bourcy, Q., Lechanteur, A., Chiap, P., & Evrard, B. (2023). How the choice of dissolution parameters influences the interpretation of dissolution efficiency from two different cannabidiol formulations? [Poster presentation]. 4th European Conference on Pharmaceutics, Marseille, France. |
 | Koch, N., Jennotte, O., Toussaint, C., Lechanteur, A., & Evrard, B. (2023). Production challenges of tablets containing lipid excipients: case study using cannabidiol as drug model. International Journal of Pharmaceutics, 122639. doi:10.1016/j.ijpharm.2023.122639 Peer Reviewed verified by ORBi |
Koch, N., Jennotte, O., Bourcy, Q., Lechanteur, A., & Evrard, B. (2023). How the choice of dissolution parameters influences the interpretation of dissolution efficiency from two different cannabidiol formulations? [Paper presentation]. CIRM day 2023. |
 | Nyamba, I., Jennotte, O., Charles B Sombié, Lechanteur, A., Sacre, P.-Y., Abdoulaye Djandé, Rasmane Semde, & Evrard, B. (2023). Preformulation study for the selection of a suitable polymer for the development of ellagic acid-based solid dispersion using hot-melt extrusion. International Journal of Pharmaceutics. doi:10.1016/j.ijpharm.2023.123088 Peer Reviewed verified by ORBi |
Dinh, T. N., Bya, L.-A., Lechanteur, A., Penoy, N., Evrard, B., & Piel, G. (2023). LIPOSOME FOR THE TREATMENT OF COPD PRODUCED BY SUPERCRITICAL CARBON DIOXIDE-BASED TECHNOLOGIES [Paper presentation]. 21st Forum of Pharmaceutical Sciences, Blankenberge, Belgium. |
Debuigne, A., Piel, G., Mottet, D., Toussaint, F., Berger, M., Ben Djemaa, S., & Lechanteur, A. (2023). Polymer Derivative and their use as lipid nanoparticle modifiers”. |
Parulski, C., Goebel, J., Bya, L.-A., Servais, A.-C., Lechanteur, A., & Evrard, B. (2023). Could 3D printed waffle shapes replace hydrocortisone capsules prepared in community pharmacies for children’s personalized medicine? [Paper presentation]. Center for Interdisciplinary Research on Medicines (CIRM) Scientific Day, Liège, Belgium. |
Bya, L.-A., Dinh, T. N., Piel, G., Lechanteur, A., & Evrard, B. (2023). Inhaled dry powder containing lipid-nanoparticles: particle engineering by spray-drying technology [Paper presentation]. 21st Forum of Pharmaceutical Sciences, Blankenberge, Belgium. |
 | Ayyoubi, S., Van Kampen, E., Kocabas, L. I., Parulski, C., Lechanteur, A., Evrard, B., De Jager, K., Muller, E., Wilms, E. W., Meulenhoff, P. W. C., & Ruijgrok, E. J. (December 2022). 3D printed, personalized sustained release cortisol for patients with adrenal insufficiency. International Journal of Pharmaceutics, 630, 122466. doi:10.1016/j.ijpharm.2022.122466 Peer Reviewed verified by ORBi |
Toussaint, F., Berger, M., Lechanteur, A., Jérôme, C., Piel, G., & Debuigne, A. (15 November 2022). Amphiphilic poly(N-vinylpyrrolidone)-based lipoplex modifiers for drug delivery applications [Paper presentation]. Belgian Polymer Group (BPG) Annual Meeting, Blankenberge, Belgium. |
Lechanteur, A. (14 November 2022). 3D printing of medicines [Paper presentation]. LDRI monthly seminar, Louvain, Belgium. |
Lechanteur, A. (November 2022). La composition des médicaments influence leur mode d’action : mais qui a-t-il dans nos médicaments ? [Paper presentation]. Grande Conférence « Cycle du médicament » de l’ULiège. |
Gresse, E., du Bois, A., Lechanteur, A., & Evrard, B. (30 September 2022). How to improve engineered micronized powder flowability? [Paper presentation]. GALENUS WORKSHOP ON RECENT DEVELOPMENTS IN PARTICLE ENGINEERING, Graz, Austria. |
 | Parulski, C., Gresse, E., Jennotte, O., Felten, A., Ziemons, E., Lechanteur, A., & Evrard, B. (31 August 2022). Fused deposition modeling 3D printing of solid oral dosage forms containing amorphous solid dispersions: How to elucidate drug dissolution mechanisms through surface spectral analysis techniques? International Journal of Pharmaceutics, 626, 122157. doi:10.1016/j.ijpharm.2022.122157 Peer Reviewed verified by ORBi |
Toussaint, F., Berger, M., Lechanteur, A., Jérôme, C., Piel, G., & Debuigne, A. (14 June 2022). Novel polyvinylpyrrolidone-based lipoplex modifiers for siRNA delivery [Poster presentation]. Bordeaux Polymer Conference, Bordeaux, France. |
Toussaint, F., Berger, M., Lechanteur, A., Jérôme, C., Piel, G., & Debuigne, A. (01 June 2022). PNVP as PEG alternative for lipoplex modification in siRNA delivery application [Poster presentation]. Advanced Functional Polymers for Medecine (AFPM), Nice, France. |
 | Jennotte, O., Koch, N., Lechanteur, A., & Evrard, B. (2022). Development of amorphous solid dispersions of cannabidiol: Influence of the carrier, the hot-melt extrusion parameters and the use of a crystallization inhibitor. Journal of Drug Delivery Science and Technology, 103372. doi:10.1016/j.jddst.2022.103372 Peer reviewed |
Lechanteur, A. (April 2022). Qualité des préparations magistrales en officine [Paper presentation]. Société Scientifique des Pharmaciens Francophones (SSPF). |
Parulski, C., Gresse, E., Jennotte, O., Lechanteur, A., & Evrard, B. (30 March 2022). How do polymer composition and infill density of 3D printed oral forms influence the dissolution rate of a BCSII molecule ? [Poster presentation]. 13th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology (PBP), Rotterdam, Netherlands. |
Berger, M., Toussaint, F., Ben Djemaa, S., Evrard, B., Jérôme, C., Lechanteur, A., Mottet, D., Debuigne, A., & Piel, G. (30 March 2022). Development of innovative grafted lipoplexes using PNVP-derivatives polymers as a PEG alternative to treat cancer [Paper presentation]. 13th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology (PBP World Meeting), Rotterdam, Netherlands. |
Jennotte, O., Koch, N., Rosoux, F., Emmerechts Carl, Beeckman Eric, Lechanteur, A., & Evrard, B. (30 March 2022). Formulation and Quality Consideration of Cannabidiol Printlets Produced by Fused-Deposition Modeling [Poster presentation]. 13th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology. |
| Nyamba, I., Jennotte, O., Charles B Sombié, Lechanteur, A., Rasmané Semdé, & Evrard, B. (27 March 2022). Polymer screening for the development of solid dispersion formulations based on ellagic acid by Hot melt extrusion [Poster presentation]. world meeting on pharmaceutics, biopharmaceutics and pharmaceutical technology, Rotterdam, Netherlands. |
 | Lechanteur, A., Plougonven, E., Orozco Ardila, L., Gresse, E., Lumay, G., Vandewalle, N., Léonard, A., & Evrard, B. (25 March 2022). Engineered-inhaled particles: influence of carbohydrates excipients nature on powder properties and behavior [Poster presentation]. PBP world meeting 2022. Peer reviewed |
Parulski, C., Gresse, E., Jennotte, O., Lechanteur, A., & Evrard, B. (10 March 2022). How do infill density and polymer composition of 3D printed solid oral forms impact the dissolution profile of a BSCII drug ? [Paper presentation]. CRS Local Chapters meeting Aachen, Aachen, Germany. |
Berger, M., Toussaint, F., Ben Djemaa, S., Evrard, B., Jérôme, C., Lechanteur, A., Mottet, D., Debuigne, A., & Piel, G. (09 March 2022). Development of innovative grafted lipoplexes using PNVP-derivatives polymers as a PEG alternative to treat cancer [Paper presentation]. 2022 Meeting of the Germany and BeNeLux & France Local Chapters of the Controlled Release Society in Aachen, Aachen, Germany. |
Koch, N., Jennotte, O., Lechanteur, A., & Evrard, B. (March 2022). Cannabidiol tablets with an enhanced bioavailability: Optimal selection of excipients and tableting through Design of Experiments [Poster presentation]. PBP 13th World Meeting, Rotterdam, Netherlands. |
Parulski, C., Gresse, E., Jennotte, O., Lechanteur, A., & Evrard, B. (02 February 2022). Developement of stable amorphous solid dispersions by hot-melt extrusion coupled with 3D printing to enhance the dissolution rate of a BCSII active molecule: Impact of infill density and polymer composition [Paper presentation]. Center for Interdisciplinary Research on Medicines (CIRM) Scientific Day, Liège, Belgium. |
Koch, N., Jennotte, O., Lechanteur, A., & Evrard, B. (02 February 2022). Development of cannabidiol lipid-dispersion tablets: excipients selection and tabletability [Paper presentation]. CIRM Day 2022. |
Berger, M., Toussaint, F., Evrard, B., Jérôme, C., Lechanteur, A., Debuigne, A., & Piel, G. (02 February 2022). PNVP-polymers as a promising polyethyleneglycol (PEG) alternative onto anti-tumor lipoplexes surface [Paper presentation]. CIRM-Day, Liege, Belgium. |
| Nyamba, I., Sombié, C., Lechanteur, A., Semdé, R., & Evrard, B. (02 February 2022). Complexation with cyclodextrins and solid dispersions formation as physical formulation approaches for improving aqueous solubility and bioavailability of ellagic acid [Paper presentation]. CIRM Day 2022, Liège, Belgium. |
Jennotte, O., Koch, N., Lechanteur, A., & Evrard, B. (02 February 2022). Formulation and Quality Consideration of Cannabidiol Printlets Produced by Fused-Deposition Modeling [Paper presentation]. CIRM DAY 2022. |
 | Koch, N., Jennotte, O., Ziemons, E., Boussard, G., Lechanteur, A., & Evrard, B. (2022). Influence of API physico-chemical properties on amorphization capacity of several mesoporous silica loading methods. International Journal of Pharmaceutics. doi:10.1016/j.ijpharm.2021.121372 Peer Reviewed verified by ORBi |
 | Lechanteur, A., Plougonven, E., Orozco, L., Lumay, G., Vandewalle, N., Léonard, A., & Evrard, B. (2022). Engineered-inhaled particles: Influence of carbohydrates excipients nature on powder properties and behavior. International Journal of Pharmaceutics, 121319. doi:10.1016/j.ijpharm.2021.121319 Peer Reviewed verified by ORBi |
Lechanteur, A. (December 2021). Mechanisms of drug delivery in the lung [Paper presentation]. Belgian Pneumology Days 2021. |
| Nyamba, I., Charle SOMBIE, Lechanteur, A., Rasmané Semdé, & Evrard, B. (03 November 2021). Augmentation de la solubilité et de la biodisponibilité de l’acide ellagique par complexation à l’aide de cyclodextrines en vue de son utilisation comme antipaludique: formulation et caractérisation par spectroscopie infrarouge à transformée de Fourier [Paper presentation]. Congrès, Ouagadougou, Burkina Faso. |
Lechanteur, A. (November 2021). Mechanisms of drug delivery in the lung [Paper presentation]. CRS IC local chapter. |
 | Parulski, C., Jennotte, O., Lechanteur, A., & Evrard, B. (August 2021). Challenges of fused deposition modeling 3D printing in pharmaceutical applications: Where are we now? Advanced Drug Delivery Reviews, 175. doi:10.1016/j.addr.2021.05.020 Peer Reviewed verified by ORBi |
 | Ilangala Booka, A., Lechanteur, A., Fillet, M., & Piel, G. (2021). Therapeutic peptides for chemotherapy: trends and challenges for advanced delivery systems. European Journal of Pharmaceutics and Biopharmaceutics. doi:10.1016/j.ejpb.2021.07.010 Peer Reviewed verified by ORBi |
 | Berger, M., Lechanteur, A., Evrard, B., & Piel, G. (2021). Innovative lipoplexes formulations with enhanced siRNA efficacy for cancer treatment: Where are we now? International Journal of Pharmaceutics. doi:10.1016/j.ijpharm.2021.120851 Peer Reviewed verified by ORBi |
Toussaint, F., Berger, M., Sanaa, B. D., Lechanteur, A., Jérôme, C., Piel, G., Mottet, D., & Debuigne, A. (27 May 2021). Polyvinylpyrrolidone compounds as PEG alternatives for lipoplex modification [Poster presentation]. Belgian Polymer Group (BPG) Annual Meeting, remote, Belgium. |
Parulski, C., Gresse, E., Jennotte, O., Lechanteur, A., & Evrard, B. (26 May 2021). How do polymer composition and infill density of 3D printed tablets influence the dissolution rate of itraconazole ? [Paper presentation]. Center for Interdisciplinary Research on Medicines (CIRM) Scientific Day, Liège, Belgium. |
Koch, N., Jennotte, O., Lechanteur, A., & Evrard, B. (14 May 2021). Improvement of fenofibrate aqueous solubility by using mesoporous silica impregnation under pressurized carbon dioxide [Poster presentation]. PBP 12th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology. |
Berger, M., Toussaint, F., Ben Djemaa, S., Evrard, B., Jérôme, C., Debuigne, A., Mottet, D., Lechanteur, A., & Piel, G. (May 2021). Impact of amphiphilic N-vinyl pyrrolidone-based polymers used as PEG alternative on lipoplexes physico-chemical properties, cytotoxicity and gene delivery [Poster presentation]. Center for Interdisciplinary Research on Medicines (CIRM) Scientific Day, Liège, Belgium. |
Parulski, C., Gresse, E., Jennotte, O., Lechanteur, A., & Evrard, B. (06 April 2021). How do infill density and polymer composition of tablets produced by hotmelt extrusion coupled with Fused Deposition Modeling 3D printing influence the dissolution profile of a BCS II molecule ? [Paper presentation]. CRS Local Chapter Meeting. |
Jennotte, O., Koch, N., Lechanteur, A., & Evrard, B. (06 April 2021). Amorphous solid dispersions of cannabidiol with an increase of the aqueous solubility: influence of the carrier, the hot melt extrusion parameters and the use of a crystallization inhibitor [Paper presentation]. The Controlled Release Society BeNeLux&France Early Career Scientists Meeting 2021. |
Koch, N., Jennotte, O., Lechanteur, A., & Evrard, B. (06 April 2021). Influence of API physico-chemical properties on amorphization capacity of several mesoporous silica loading methods [Paper presentation]. CRS BNFL ECS Meeting 2021. |
Berger, M., Toussaint, F., Pairoux, C., Evrard, B., Jérôme, C., Lechanteur, A., Debuigne, A., & Piel, G. (06 April 2021). Amphiphilic N-vinyl pyrrolidone-based polymers as PEG alternatives to avoid blood proteins adsorption around liposomes [Paper presentation]. Early Career Scientist Meeting 2021. |
Parulski, C., Gresse, E., Jennotte, O., Lechanteur, A., & Evrard, B. (04 March 2021). Investigation of the impact of polymer composition and infill density of solid oral forms produced by hot-melt extrusion coupled with 3D printing on the dissolution rate of itraconazole [Paper presentation]. CRS Local Chapter Meeting, Aachen, Germany. |
Berger, M., Toussaint, F., Pairoux, C., Evrard, B., Jérôme, C., Lechanteur, A., Debuigne, A., & Piel, G. (04 March 2021). Impact of amphiphilic copolymer used as PEG alternative on the formation of a protein corona around coated-liposomes encapsulating siRNA [Paper presentation]. 2021 - Virtual Local Chapter Meeting Germany and BeNeLux & France, Aachen, Germany. |
 | Bellefroid, C., Reusch, C., Lechanteur, A., Evrard, B., Debacq-Chainiaux, Mottet, D., & Piel, G. (2021). Systematic study of liposomes composition towards efficient delivery of plasmid DNA as potential application of dermal fibroblasts targeting. International Journal of Pharmaceutics, 592, 120122. doi:10.1016/j.ijpharm.2020.120122 Peer Reviewed verified by ORBi |
 | Delma, K. L., Lechanteur, A., Semde, R., Evrard, B., & Piel, G. (2021). Sterilization methods of liposomes: drawbacks of conventional methods and perspectives. International Journal of Pharmaceutics. doi:10.1016/j.ijpharm.2021.120271 Peer Reviewed verified by ORBi |
 | Nyamba, I., Lechanteur, A., Semdé, R., & Evrard, B. (2020). Physical formulation approaches for improving aqueous solubility and bioavailability of ellagic acid: A review. European Journal of Pharmaceutics and Biopharmaceutics. doi:10.1016/j.ejpb.2020.11.004 Peer Reviewed verified by ORBi |
 | Koch, N., Jennotte, O., Grignard, B., Lechanteur, A., & Evrard, B. (01 July 2020). Impregnation of mesoporous silica with poor aqueous soluble molecule using pressurized carbon dioxide: is the solubility in the supercritical and subcritical phase a critical parameter? European Journal of Pharmaceutical Sciences, 150, 105332. doi:10.1016/j.ejps.2020.105332 Peer Reviewed verified by ORBi |
 | Lechanteur, A., & Evrard, B. (2020). Influence of Composition and Spray-Drying Process Parameters on Carrier-Free DPI Properties and Behaviors in the Lung: A review. Pharmaceutics. doi:10.3390/pharmaceutics12010055 Peer Reviewed verified by ORBi |
 | Jennotte, O., Koch, N., Lechanteur, A., & Evrard, B. (2020). Three-dimensional printing technology as a promising tool in bioavailability enhancement of poorly water-soluble molecules: a review. International Journal of Pharmaceutics. doi:10.1016/j.ijpharm.2020.119200 Peer Reviewed verified by ORBi |
 | Koch, N., Jennotte, O., Gasparrini, Y., Vandenbroucke, F., Lechanteur, A., & Evrard, B. (2020). Cannabidiol aqueous solubility enhancement: comparison of three amorphous formulations strategies using different type of polymers. International Journal of Pharmaceutics. doi:10.1016/j.ijpharm.2020.119812 Peer Reviewed verified by ORBi |
 | Schmitt, C., Lechanteur, A., Cossais, F., Bellefroid, C., Arnold, P., Lucius, R., Held-Feindt, J., Piel, G., & Hattermann, K. (2020). Liposomal Encapsulated Curcumin Effectively Attenuates Neuroinflammatory and Reactive Astrogliosis Reactions in Glia Cells and Organotypic Brain Slices. International Journal of Nanomedicine, 15, 3649—3667. doi:10.2147/IJN.S245300 Peer reviewed |
 | Bellefroid, C., Lechanteur, A., Evrard, B., Mottet, D., Debacq-Chainiaux, F., & Piel, G. (15 December 2019). In vitro skin penetration enchancement techniques: a combined approach of ethosomes and microneedles. International Journal of Pharmaceutics, 572. doi:10.1016/j.ijpharm.2019.118793 Peer Reviewed verified by ORBi |
Bellefroid, C., Lechanteur, A., Evrard, B., & Piel, G. (11 December 2019). Lipid-based nanovectors combined with microneedles to enhance skin penetration of genes: in vitro and in vivo studies [Paper presentation]. 2nd CIRM DAY, Liège, Belgium. |
Koch, N., Jennotte, O., Lechanteur, A., & Evrard, B. (11 December 2019). Improvement of fenofibrate aqueous solubility by using mesoporous silica impregnation under pressurized carbon dioxide [Paper presentation]. 2nd CIRM Day. |
Jennotte, O., Koch, N., Lechanteur, A., & Evrard, B. (11 December 2019). Hot-melt extrusion as a solvent-free technique for the formation of a polymeric amorphous solid dispersion of atorvastatin [Paper presentation]. Second scientific CIRM day, Liège, Belgium. |
Nyamba, I., Lechanteur, A., Evrard, B., & SEMDE, R. (11 December 2019). Improvement water-solubility of ellagic acid for use as an antimalarial drug through oral administration [Poster presentation]. CIRM DAY, LIEGE, Belgium. |
 | Ilangala Booka, A., COBRAIVILLE, G., EVRARD, A., Sonveaux, Lechanteur, A., Piel, G., & Fillet, M. (11 December 2019). LC-UV as tool for nanovectorized anticancer peptide quality control: evaluation of encapsulation efficiency [Poster presentation]. 2nd Edition of CIRM day, Liege, Belgium. |
 | Lechanteur, A., Evrard, B., & Piel, G. (11 December 2019). Assessment of the feasibility to develop a fast and easy reproducible 3D bronchial model growing at the air-liquid interface: Which critical culture parameters must be controlled? [Poster presentation]. 2nd CIRM Day. |
 | Sounouvou, A. G. H. T., Toukourou, H., Lechanteur, A., Piel, G., Quetin-Leclercq, J., Gbaguidi, F., & Evrard, B. (11 December 2019). Development of dermatological dosage forms based on essential oils for the treatment of common skin infections [Paper presentation]. 2nd CIRM day, Liege, Belgium. |
 | Sounouvou, A. G. H. T., Lechanteur, A., Quetin-Leclercq, J., Piel, G., Donneau, A.-F., Gbaguidi, F., & Evrard, B. (2019). Chromametric assessment of drug skin tolerance: A comparative study between Africans and Caucasians skins. Skin Research and Technology. doi:10.1111/srt.12804 Peer Reviewed verified by ORBi |
| Nyamba, I., Charles Sombié, Lechanteur, A., Rasmané Semdé, & Evrard, B. (27 October 2019). Amélioration de la solubilité et de la biodisponibilité de l’acide ellagique en vue de son utilisation comme antipaludique [Paper presentation]. Congrès, Abidjan, Côte d’Ivoire. |
Bellefroid, C., Lechanteur, A., Evrard, B., & Piel, G. (24 September 2019). Nucleic acids skin penetration enhancement: a combined approach of deformable liposomes and microneedles [Paper presentation]. Skin & Formulation 5th Symposium & 17th Skin Forum, Reims, France. |
 | Lechanteur, A., Evrard, B., & Piel, G. (2019). Assessment of the feasibility to develop a fast and easy reproducible 3D bronchial model growing at the air-liquid interface: Which critical culture parameters must be controlled? European Journal of Pharmaceutics and Biopharmaceutics. doi:10.1016/j.ejpb.2019.09.001 Peer Reviewed verified by ORBi |
Jennotte, O., Koch, N., Rocks, N., Lechanteur, A., & Evrard, B. (20 May 2019). Development of new manufacturing processes for amorphous solid dispersions [Paper presentation]. 20th forum of pharmaceutical sciences, Bruxelles, Belgium. |
Bellefroid, C., Lechanteur, A., Evrard, B., & Piel, G. (20 May 2019). Improvement of skin penetration of lipid-based nanocarriers according to their composition [Paper presentation]. 20th Forum of Pharmaceutical Sciences, Bruxelles, Belgium. |
 | Koch, N., Jennotte, O., Rocks, N., Lechanteur, A., & Evrard, B. (20 May 2019). Mesoporous silica impregnation using supercritical carbon dioxide: is the solubility in the supercritical fluid a critical parameter? [Paper presentation]. 20th Forum of Pharmaceutical Sciences, Bruxelles, Belgium. |
Jennotte, O., Koch, N. (Other coll.), Collard, L. (Other coll.), Lechanteur, A. (Other coll.), & Evrard, B. (Other coll.). (26 March 2019). Hot melt extrusion as a solvent-free technique for the formation of a polymeric amorphous solid dispersion of atorvastatin [Poster presentation]. 3rd European Conference on Pharmaceutics, Bologne, Italy. |
Koch, N., Jennotte, O., Rocks, N., Lechanteur, A., & Evrard, B. (26 March 2019). Impregnation of mesoporous silica using supercritical-CO2: is the solubility in the supercritical fluid a critical paramter? [Poster presentation]. 3rd European Conference on Pharmaceutics, Bologne, Italy. |
Bellefroid, C., Lechanteur, A., Evrard, B., & Piel, G. (25 March 2019). Enhancement of skin penetration of lipid-based nanocarriers [Paper presentation]. 3th European Conference on Pharmaceutics, Bologne, Italy. |
 | Bellefroid, C., Lechanteur, A., Evrard, B., & Piel, G. (2019). Lipid gene nanocarriers for the treatment of skin diseases: current state-of-the-art. European Journal of Pharmaceutics and Biopharmaceutics. doi:10.1016/j.ejpb.2019.02.012 Peer Reviewed verified by ORBi |
Bellefroid, C., Lechanteur, A., Evrard, B., & Piel, G. (19 December 2018). Enhancement of skin penetration of lipid-based nanocarriers [Paper presentation]. 1st CIRM Scientific Day, Liège, Belgium. |
Jennotte, O., Koch, N., Collard, L., Lechanteur, A., & Evrard, B. (19 December 2018). Hot melt extrusion as a solvent-free technique for the formation of a polymeric amorphous solid dispersion of atorvastatin [Paper presentation]. CIRM Day, Liège, Belgium. |
Koch, N., Jennotte, O., Rocks, N., Lechanteur, A., & Evrard, B. (December 2018). Impregnation of mesoporous silica with fenofibrate using supercritical-CO2: is the solubility a critical parameter? [Paper presentation]. 1st CIRM scientific Day, Liège, Belgium. |
 | Lechanteur, A., Sanna, V., Duchemin, A., Evrard, B., Mottet, D., & Piel, G. (August 2018). Cationic Liposomes Carrying siRNA: Impact of Lipid Composition on Physicochemical Properties, Cytotoxicity and Endosomal Escape [Paper presentation]. 12th International Conference and Workshop on Biological barriers, Saarbruck, Germany. |
Bellefroid, C., Lechanteur, A., Evrard, B., & Piel, G. (August 2018). Assessment of skin penetration of classical and deformable liposomes [Poster presentation]. 12th International Conference and Workshop on Biological Barriers, Saarbrücken, Germany. |
Bellefroid, C., Lechanteur, A., Evrard, B., & Piel, G. (12 July 2018). Assessment of skin penetration of classical and deformable liposomes [Paper presentation]. First NANOMED EMJMD's Workshop, Paris, France. |
 | Angeli de Lima, I., Maissar Khalil, N., Toyomi Tominaga, T., Lechanteur, A., Sarmento, B., & Mara Mainardes, R. (2018). Mucoadhesive chitosan-coated PLGA nanoparticles for oral delivery of ferulic acid. Artificial Cells, Nanomedicine and Biotechnology. doi:10.1080/21691401.2018.1477788 Peer Reviewed verified by ORBi |
| Lechanteur, A., Sanna, V., Duchemin, A., Evrard, B., Mottet, D., & Piel, G. (2018). Cationic Liposomes Carrying siRNA: Impact of Lipid Composition on Physicochemical Properties, Cytotoxicity and Endosomal Escape. In Cationic liposomes carrying siRNA: impact of lipid composition on physicochemical properties, cytotoxicity and endosomal escape. Peer reviewed |
Piel, G., Lechanteur, A., & Cao, M. (17 January 2018). Update on the progresses and development prospects of the unifying theme "nanomedicine" within CIRM [Paper presentation]. CIRM seminar, Liege, Belgium. |
Pereira, I., Lechanteur, A., & Sarmento, B. (2018). 3D Model Replicating the Intestinal Function to Evaluate Drug Permeability. In Epithelial Cell Culture: Methods and Protocols. Springer Nature. doi:10.1007/978-1-4939-8600-2_11 Peer reviewed |
 | Lechanteur, A., Sanna, V., Duchemin, A., Evrard, B., Mottet, D., & Piel, G. (2018). Cationic Liposomes Carrying siRNA: Impact of Lipid Composition on Physicochemical Properties, Cytotoxicity and Endosomal Escape. Nanomaterials, 8 (5). doi:10.3390/nano8050270 Peer Reviewed verified by ORBi |
 | Boni, F. I., Almeida, A., Lechanteur, A., Sarmento, B., Stringhetti Ferreira Cury, B., & Palmira Daflon Gremião, M. (01 January 2018). Mucoadhesive nanostructured polyelectrolytes complexes modulate the intestinal permeability of methotrexate. European Journal of Pharmaceutical Sciences, 111. doi:10.1016/j.ejps.2017.09.042 Peer Reviewed verified by ORBi |
 | Lechanteur, A., Furst, T., Delvenne, P., Evrard, B., Hubert, P., & Piel, G. (07 December 2017). Promoting vaginal distribution of two active siRNA-complexed in liposomes for cervical cancer treatment [Paper presentation]. SF Nano Annual Meeting 2017, Bordeaux, France. |
 | Lechanteur, A., Furst, T., Delvenne, P., Evrard, B., Hubert, P., & Piel, G. (05 December 2017). Promoting vaginal distribution of two active siRNA-complexed in liposomes for cervical cancer treatment [Paper presentation]. 4th SF Nano Annual Meeting, Bordeaux, France. |
| Sgorla, D., Lechanteur, A., Almeida, A., Sousa, F., Melo, E., Bunhak, É., Mainardes, R., Khalil, N., Cavalcanti, O., & Sarmento, B. (2017). Development and characterization of lipid-polymeric nanoparticles for oral insulin delivery. Expert Opinion on Drug Delivery. doi:10.1080/17425247.2018.1420050 Peer Reviewed verified by ORBi |
 | Lechanteur, A., das Neves, J., & Sarmento, B. (2017). The role of mucus in cell-based models used to screen mucosal drug delivery. Advanced Drug Delivery Reviews. doi:10.1016/j.addr.2017.07.019 Peer Reviewed verified by ORBi |
 | Lechanteur, A., Almeida, A., & Sarmento, B. (2017). Elucidation of the impact of cell culture conditions of Caco-2 cell monolayer on barrier integrity and intestinal permeability. European Journal of Pharmaceutics and Biopharmaceutics. doi:10.1016/j.ejpb.2017.06.013 Peer Reviewed verified by ORBi |
| Lechanteur, A., Furst Tania, Evrard, B., Delvenne, P., Hubert, P., & Piel, G. (25 April 2017). Promoting vaginal distribution of two active siRNA-complexed in liposomes for cervical cancer treatment [Paper presentation]. 1st SPLC-Controlled Release Society, Santiago de Compostela, Spain. |
 | Lechanteur, A., Furst, T., Delvenne, P., Evrard, B., Hubert, P., & Piel, G. (04 April 2017). Promoting vaginal distribution of two active siRNA-complexed in liposomes for cervical cancer treatment [Paper presentation]. 2nd European Conference on Pharmaceutics: Drug Delivery, Krakow, Poland. |
 | Lechanteur, A., Furst, T., Delvenne, P., Evrard, B., Piel, G., & Hubert, P. (2017). Promoting vaginal distribution of E7 and MCL-1 siRNA-silencing nanoparticles for cervical cancer treatment. Molecular Pharmaceutics. doi:10.1021/acs.molpharmaceut.6b01154 Peer Reviewed verified by ORBi |
Lechanteur, A., Furst, T., Evrard, B., DELVENNE, P., Hubert, P., & Piel, G. (27 September 2016). FINDING THE RIGHT BALANCE BETWEEN EFFECTIVENESS, TOXICITY AND VAGINAL DIFFUSION OF siRNA LIPOPLEXES FOR CERVICAL CANCER TREATMENT [Poster presentation]. 4th Conference on Innovation in Drug Delivery: Site specific drug delivery, Antibes, France. |
Furst, T., Dakwar, G., zagato, E., Lechanteur, A., Remaut, K., Evrard, B., De Smedt, S., & Piel, G. (26 September 2016). MUCOADHESIVE SPONGES WITH PEGYLATED LIPOPLEXES: TOWARDS A SUSTAINED VAGINAL DELIVERY OF siRNA [Poster presentation]. 4th Conference on Innovation in Drug Delivery: Site specific drug delivery, Antibes, France. |
 | Lechanteur, A. (2016). Développement et optimisation de nanovecteurs de type lipoplexes pour une application vaginale en vue de traiter des lésions induites par HPV [Doctoral thesis, ULiège - Université de Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/215358 |
 | Lechanteur, A., Furst, T., Evrard, B., Delvenne, P., Hubert, P., & Piel, G. (August 2016). PEGylation of lipoplexes: The right balance between cytotoxicity and siRNA effectiveness. European Journal of Pharmaceutical Sciences, 93, 493-593. doi:10.1016/j.ejps.2016.08.058 Peer Reviewed verified by ORBi |
| Furst, T., Bettonville, V., Farcas, E., Frère, A., Lechanteur, A., Evrard, B., Fillet, M., Piel, G., & Servais, A.-C. (2016). Capillary electrophoresis method to determine siRNA complexation with cationic liposomes. Electrophoresis. doi:10.1002/elps.201600249 Peer Reviewed verified by ORBi |
 | Furst, T., Dakwar, G. R., Zagato, E., Lechanteur, A., Remaut, K., Evrard, B., Braeckmans, K., & Piel, G. (2016). Freeze-dried mucoadhesive polymeric system containing pegylated lipoplexes: Towards a vaginal sustained released system for siRNA. Journal of Controlled Release. doi:10.1016/j.jconrel.2016.06.028 Peer Reviewed verified by ORBi |
| Lechanteur, A., Furst, T., Delvenne, P., Evrard, B., Hubert, P., & Piel, G. (28 May 2015). DEVELOPMENT OF LIPOPLEXES FOR A TOPICAL TREATMENT OF HPV16 INDUCED LESIONS: In vitro and ex vivo studies [Paper presentation]. 18th Forum of Pharmaceutical Sciences, Blankenberg, Belgium. |
| Lechanteur, A., Furst, T., Evrard, B., Delvenne, P., Piel, G., & Hubert, P. (13 May 2015). Anti-E6/E7/MCL1 pegylated lipoplexes for a topical treatment of HPV16 induced lesions [Paper presentation]. GIGA-Cancer Day 2015, Liege, Belgium. |
| Lechanteur, A., Furst, T., Evrard, B., Delvenne, P., Piel, G., & Hubert, P. (14 April 2015). Anti-E6/E7/MCL1 pegylated lipoplexes for a vaginal treatment of cervical cancer [Paper presentation]. 1st European Conference on Pharmaceutics Drug Delivery, Reims, France. |
Furst, T., Lechanteur, A., Evrard, B., & Piel, G. (13 April 2015). Mucoadhesive hydroxyethyl-cellulose sponges as lipoplexes delivery system for vaginal application [Poster presentation]. 1st European Conference on Pharmaceutics: Drug Delivery, Reims, France. |
 | Lechanteur, A.* , Furst, T.* , Evrard, B., Delvenne, P., Hubert, P., & Piel, G. (16 February 2015). Development of anti-E6 pegylated lipoplexes for mucosal application in the context of cervical preneoplastic lesions. International Journal of Pharmaceutics, 483, 268-277. doi:10.1016/j.ijpharm.2015.02.041 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
 | Lechanteur, A., Furst, T., Evrard, B., Delvenne, P., Piel, G., & Hubert, P. (11 February 2015). Anti-E6/E7/MCL1 pegylated lipoplexes for a topical treatment of cervical (pre)neoplastic lesions [Poster presentation]. Séminaire des chercheurs Télévie 2015, Bruxelles, Belgium. |
 | Furst, T., Piette, M., Lechanteur, A., Evrard, B., & Piel, G. (2015). Mucoadhesive cellulosic derivative sponges as drug delivery system for vaginal application. European Journal of Pharmaceutics and Biopharmaceutics. doi:10.1016/j.ejpb.2015.01.019 Peer Reviewed verified by ORBi |
| Lechanteur, A., Furst, T., Delvenne, P., Evrard, B., Hubert, P., & Piel, G. (2015). Anti-E6/E7/MCL-1 pegylated lipoplexes for a vaginal treatment of cervical cancer [Paper presentation]. 1st European Conference on Pharmaceutics: Drug Delivery, Reims, France. |
| Furst, T., Lechanteur, A., Hubert, P., Evrard, B., & Piel, G. (03 November 2014). DEVELOPMENT AND CHARACTERIZATION OF PEGYLATED LIPOPLEXES TO BE ENTRAPPED IN HEC SPONGES FOR VAGINAL DELIVERY [Poster presentation]. 2014 AAPS Annual Meeting and Exposition, San Diego, United States. |
| Furst, T., Lechanteur, A., Hubert, P., Evrard, B., & Piel, G. (20 October 2014). DEVELOPMENT AND CHARACTERIZATION OF PEGYLATED LIPOPLEXES TO BE ENTRAPPED IN HEC SPONGES FOR VAGINAL DELIVERY [Poster presentation]. 3rd NanoFar Autumn School, Louvain, Belgium. |
| Lechanteur, A., Furst, T., Kanber, E., Evrard, B., Delvenne, P., Piel, G., & Hubert, P. (04 October 2014). Development and optimization of pegylated lipoplexes for vaginal application [Paper presentation]. SFNano Workshop 2014, Porto, Portugal. |
| Furst, T., Lechanteur, A., Hubert, P., Evrard, B., & Piel, G. (27 August 2014). DEVELOPMENT OF PEG-COATED LIPOPLEXES TO BE INCORPORATED INTO MUCOADHESIVE HEC-SPONGES [Poster presentation]. Translational Nanomedicine, International Meeting, Angers, France. |
| Lechanteur, A., Furst, T., Evrard, B., Delvenne, P., Piel, G., & Hubert, P. (19 May 2014). ASSOCIATION OF LIPOSOMES AND siRNA FOR A LOCAL TREATMENT OF CERVICAL CANCER [Poster presentation]. GIGA-Cancer Day 2014. |
| Furst, T., Lechanteur, A., Hubert, P., Evrard, B., & Piel, G. (03 April 2014). DEVELOPMENT OF PEG-COATED LIPOPLEXES WITH siRNA ANTI E6/E7 ONCOPROTEINS FOR THE TREATMENT OF HPV CANCERS [Poster presentation]. 9th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, Lisbonne, Portugal. |
| Furst, T., Lechanteur, A., Hubert, P., Evrard, B., & Piel, G. (16 February 2014). Development of PEG-coated lipoplexes with siRNA anti-E6/E7 oncoproteins to be incorporated into mucoadhesive HEC-sponges for the treatment of HPV cancers [Poster presentation]. 10th International Conference and Workshop on Biological Barriers, Saarbrucken, Germany. |
| Lechanteur, A., Furst, T., Evrard, B., Delvenne, P., Piel, G., & Hubert, P. (16 February 2014). Development of anti-HPV lipoplexes formulations for the treatment of cervical cancer [Poster presentation]. 10th International conference and workshop on Biological Barriers. |
| Lechanteur, A., Furst, T., Evrard, B., Delvenne, P., Piel, G., & Hubert, P. (27 January 2014). Development of anti-HPV lipoplexes formulations for the treatment of cervical cancer [Poster presentation]. GIGA-Day 2014. |
| Lechanteur, A., Furst, T., Evrard, B., Delvenne, P., RONCARATI, P., Piel, G., & Hubert, P. (05 December 2013). Development of anti-HPV lipoplexes formulations for the treatment of cervical cancer [Poster presentation]. Séminaire des chercheurs du Télévie 2014. |
| Lechanteur, A., Furst, T., Evrard, B., Delvenne, P., Piel, G., & Hubert, P. (03 December 2013). Development of anti-HPV lipoplexes for the treatment of cervical cancer [Paper presentation]. 28ième Journées Scientifiques du GTRV, Angers, France. |
| Furst, T., Lechanteur, A., Hubert, P., Evrard, B., & Piel, G. (02 December 2013). Development of peggylated lipoplexes with siRNA anti-E6/E7 oncoproteins for the treatment og cancers induced by HPV [Poster presentation]. GTRV, Orléans, France. |
| Lechanteur, A., Furst, T., Evrard, B., Delvenne, P., Piel, G., & Hubert, P. (17 October 2013). Development of anti-HPV lipoplexes for the treatment of cervical cancer [Paper presentation]. Dix-septième forum des sciences pharmaceutiques. |
Lechanteur, A., Furst, T., Evrard, B., Delvenne, P., Piel, G., & Hubert, P. (17 June 2013). Développement et optimisation de vecteur de type lipoplexe pour une approche thérapeutique antisens dans le cadre de lésions induites par HPV [Paper presentation]. Séminaire C.I.R.M. |
| Lechanteur, A., Furst, T., Evrard, B., Delvenne, P., RONCARATI, P., Piel, G., & Hubert, P. (2013). Development of anti-HPV lipoplexes for the treatment of cervical cancer [Poster presentation]. Cancer GIGA-Day 2013, liège, Belgium. |
| Lechanteur, A., Evrard, B., Delvenne, P., RONCARATI, P., Hubert, P., & Piel, G. (November 2012). Development and optimization of lipoplex vectors for an antisens therapeutic approach in the context of HPV induced lesions [Poster presentation]. Ecole doctorale en cancérologie expérimentale, liège, Belgium. |
| Furst, T., Lechanteur, A., Evrard, B., Delvenne, P., Hubert, P., Piette, M., & Piel, G. (22 October 2012). Development of a topical formulation containing lipoplexes able to inhibit E6 and E7 genes for the treatment of cervix cancer caused by HPV16 and HPV18 [Poster presentation]. NanoFar 1st Autumn School, Angers, France. |
| Lechanteur, A., Furst, T., Evrard, B., Delvenne, P., Hubert, P., & Piel, G. (22 October 2012). Development of a topical formulation containing lipoplexes able to inhibit E6 and E7 genes for the treatment of cervix cancer caused by HPV16 and HPV18 [Poster presentation]. NanoFar Automn School, Angers, France. |
Dataset: